A hematological and inflammatory marker-based model for prostate carcinoma diagnosis

Prostate carcinoma (PC) is the most frequently diagnosed malignancy and the third leading cause of cancer-related death among men in the United States, with over 160,000 new cases reported annually. While prostate-specific antigen (PSA) screening has advanced the early detection and management of PC...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of cancer research Jg. 15; H. 6; S. 2551
Hauptverfasser:	Guo, Peiyi, A, Garu, Chen, Tao, Guo, Yuanqing, Tang, Yubo, Pan, Jiangang, Wang, Bin, Gong, Rui, Chen, Guangfu, Huang, Sheng
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.01.2025
Schlagworte:	risk Hematology clinical significance diagnostic model prostate carcinoma
ISSN:	2156-6976, 2156-6976
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!